Stem cells were supposed to be the magic bullet in regenerative medicine and they are being used in experimental therapies in humans. However, it is possible that animals, which often suffer from autoimmune diseases, will also benefit from them. A promising product is Bioceltix’s arthritis drug, which will soon be tested clinically. One in four…
Massmedica has signed an agreement to purchase the Manor and Park Complex in Bykowce, which will be transformed into a holistic rehabilitation centre. There are also plans to build a rehabilitation hospital for patients from private hospitals who will require post-surgical or post-traumatic rehabilitation. Massmedica is a company that operates within reconstructive, regenerative, sports and…
Scientists from the Australian National University, in collaboration with the Florey Institute of Neuroscience and Mental Health, have developed a hydrogel that could be used as a one-time therapy to treat Parkinson’s disease. Clinical trials may begin within the next five years, after the gel proves safe for human use. Nearly 100,000 people suffering from…
Bioceltix, one of the new hopes in the Polish biotechnology arena, has published an information memorandum stating that it plans to raise up to PLN 7.4m through a public offering of up to 360,000 new issue shares. In addition, the Wroclaw-based company plans to debut on the NewConnect stock exchange in the second quarter of…
Polski Bank Komorek Macierzystych (PBKM), a leading European company in the segment of umbilical cord blood storage and warehousing, has acquired a 70% stake in a cord blood bank in Turkey from Acibadem. PBKM pursues the acquisition target Acibadem Labcell Umbilical Cord Blood Bank has been operating until now within the Acibadem Helathcare Group, a…
Bioceltix, a Wroclaw-based start-up, is starting a project to develop a biological drug for veterinary medicine. Based on stem cells, the product will be used to treat, among others, equine arthritis in horses. NCBR grant will support veterinary medicine The Bioceltix project was ranked 1st on the latest ranking list of the National Centre for…
In June 2019, the subsidiary of PBKM announced its intention to acquire two companies operating in the stem cell segment. The transaction may be finalised later this year. PBKM – the appetite for new acquisitions On 5th June 2019, PBKM’s subsidiary – Stemlab – concluded an agreement to acquire 65% of shares in Bebecord Stemlife…
Polski Bank Komorek Macierzystych (PBKM) has announced that it has decided not to negotiate the purchase of part of Cryo-Save’s business from Dutch Esperite NV. No agreement on the terms of disposal In February, PBKM and Esperite, a Dutch biotechnology company, signed a memorandum of understanding regarding the potential acquisition by the Polish company of…
Jeff Bezos is investing in a startup called Altos Labs, which will do research into reversing the ageing process. The company wants to develop technology to “biologically reprogram” the human body so that aged cells can be regenerated. Many wealthy entrepreneurs, including Larry Page and Peter Thiel, are interested in similar projects. Altos Labs is…
Israel’s Covid drug EXO-CD24, subjected to Phase II trials in Athens, allowed 29 out of 30 moderate to severe patients to recover in up to 5 days. The Phase II trial confirmed the results of Phase I, conducted in Israel last winter. About 93% of 90 patients with severe COVID-19 were treated with the novel Israeli medication produced…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.